Corporate calendar for Equillium, Inc. (EQ): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Equillium, Inc. is a clinical-stage biopharmaceutical company focused on developing and bringing to market products designed to address severe autoimmune and inflammatory (immuno-inflammatory) disorders where current treatment options are insufficient. The company's primary drug candidate is itolizumab (EQ001), a monoclonal antibody in clinical development that targets the novel CD6 immune checkpoint receptor.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-14 | $0.03 | $1M |
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 | $144M | |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 |
Price
| Price | $1.85 |
| Market Cap | $117M |
| Exchange | NASDAQ |
| Country | US |
Related companies: COEP · CUE · FBIO · IPSC · MDCX · NRXP · OSTX
Explore sector: Healthcare · Biotechnology
More sections of EQ: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks